AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2025
Sep 4, 2025
30786_dirs_2025-09-03_95e32e3f-577c-4bb3-8c59-92be543488b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIO.B)
CIK: 0000012208
Period of Report: 2025-09-01
Reporting Person: BARRY JAMES (EVP, President, LSG)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-01 | Bio-Rad A Common Stock | M | 602 | — | Acquired | 748.555 | Direct |
| 2025-09-01 | Bio-Rad A Common Stock | F | 217 | $297.88 | Disposed | 531.555 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-01 | Restricted Stock Units | $0 | M | 178 | Disposed | Bio-Rad A Common Stock (178) | Direct | |
| 2025-09-01 | Restricted Stock Units | $0 | M | 174 | Disposed | Bio-Rad A Common Stock (174) | Direct | |
| 2025-09-01 | Restricted Stock Units | $0 | M | 250 | Disposed | Bio-Rad A Common Stock (250) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4: On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5: On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.